Support By : Li-lab
| GENE_SYMBOL | HGNC_ID | UNIPROT_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| ACVR2A | HGNC:173 | P27037 | Neratinib | 9915743 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Tofacitinib | 9926791 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Mln-120B | 9929127 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Cediranib | 9933475 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Masitinib | 10074640 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Pazopanib | 10113978 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Selumetinib | 10127622 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | 1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl- | 10138259 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Afatinib | 10184653 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Tg100-115 | 10427712 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Pha-665752 | 10461815 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | 2-Cycloheptyl-4-[4-methoxy-3-(5-phenylpentoxy)phenyl]-4a,5,8,8a-tetrahydrophthalazin-1-one | 11113983 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Tamatinib | 11213558 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Brivanib | 11234052 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | (2s)-1-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-Phenylpropan-2-Amine | 11314340 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | 11338033 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | 4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide | 11364421 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Ast-487 | 11409972 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | Linifanib | 11485656 | BindingDB |
| ACVR2A | HGNC:173 | P27037 | GW-2580 | 11617559 | BindingDB |